Cargando…
Targeting the Innate Immune Kinase IRAK1 in Radioresistant Cancer: Double-Edged Sword or One-Two Punch?
Antitumor immunity has emerged as a favorable byproduct of radiation therapy (RT), whereby tumor-associated antigens released from irradiated cells unleash innate and adaptive attacks on tumors located both within and outside the radiation field. RT-induced immune responses further provide actionabl...
Autores principales: | Liu, Peter H., Sidi, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6866135/ https://www.ncbi.nlm.nih.gov/pubmed/31799178 http://dx.doi.org/10.3389/fonc.2019.01174 |
Ejemplares similares
-
MSCs can be a double-edged sword in tumorigenesis
por: Zhang, Lu, et al.
Publicado: (2022) -
Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword
por: Ebermeyer, Théo, et al.
Publicado: (2021) -
Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression
por: Mayfosh, Alyce J., et al.
Publicado: (2019) -
Cellular senescence: a double-edged sword in cancer therapy
por: Xiao, Shuai, et al.
Publicado: (2023) -
Immunity to PRRSV: Double-edged sword
por: Molitor, T.W., et al.
Publicado: (1997)